Viewing Study NCT05624918


Ignite Creation Date: 2025-12-25 @ 4:52 AM
Ignite Modification Date: 2025-12-26 @ 3:53 AM
Study NCT ID: NCT05624918
Status: RECRUITING
Last Update Posted: 2025-07-31
First Post: 2022-11-02
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma
Sponsor: Ashish Manne
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module